نتایج جستجو برای: gbm

تعداد نتایج: 6333  

Background and Aim: Glioblastoma multiforme (GBM) is the most common malignant and invasive tumor of the brain. The relation between prognosis and survival of GBM patients with Epidermal Growth Factor Receptor (EGFR) expression is challenging. Thus, we aimed to evaluate the prognosis and survival of patients with GBM and its relationship with EGFR expression. Materials and Methods: This single...

Babak Alijani, Hamid Behzadnia, Mohammadreza Emamhadi, Shahrokh Yousefzadeh-Chabok, Zahra Haghdoost,

Background & Aim: Glioblastoma multiforme (GBM), the highest grade glioma (grade IV), is the most malignant form of astrocytoma in adults. This study aimed at evaluating the relationship between demographic, clinical and medical factors with GBM outcome. Methods & Materials/Patients: Through a cross-sectional design, 58 patients with newly diagnosed GBM were studied from 1999 to 2015 in Guil...

Objective(s):P In vitro chemosensitivity and resistance assays (CSRAs) are a promising tool for personalized treatment of glioblastoma multiform (GBM). These assays require a minimum of 1 to 2 g of tumor specimen for testing, but this amount is not always accessible. We aimed to assess the feasibility and validity of utilizing stereotactic biopsies of GBM in CSRAs. Materials and Methods: Single...

2014
Serdar Bozdag Aiguo Li Mehmet Baysan Howard A Fine

Glioblastoma multiforme (GBM) is the most common malignant brain tumor. GBM samples are classified into subtypes based on their transcriptomic and epigenetic profiles. Despite numerous studies to better characterize GBM biology, a comprehensive study to identify GBM subtype- specific master regulators, gene regulatory networks, and pathways is missing. Here, we used FastMEDUSA to compute master...

2016
Chien-Yu Kao Yi-Chao Hsu Ing-Ming Chiu

Glioblastoma (GBM) is a highly malignant brain tumor. The GBM tumor mass contains a unique cell population, GBM stem cells (GBM-SCs), which possess the self-renewal, tumor initiating and tumor progression. FGF1B is the major transcriptional variant of FGF1 in GBM. In our recent study, we demonstrated the FGF1B transcript is up-regulated in self-renewing GBM cells. In order to study GBM-SCs, we ...

Ahmad Fakharian Zinat Asadi

 This paper investigates on control and stabilization of a new hyperchaotic system. The hyperchaotic system is stabilized using a new technique which called Generalized Backstepping Method (GBM). Because of its similarity to Backstepping approach, this method is called GBM. But, this method is more applicable in comparison with conventional Backstepping.  Backstepping method is used only for sy...

2016
Patricia Liu Sana Waheed Lamya Boujelbane Laura J. Maursetter

Anti-glomerular basement membrane (GBM) disease is commonly a monophasic illness. We present the case of multiple recurrences of anti-GBM disease with varying serum anti-GBM antibody findings. A 33-year-old female tobacco user presenting with hematuria was diagnosed with anti-GBM disease by renal biopsy. Five years later, she presented with alveolar hemorrhage and positive anti-GBM antibody. Sh...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2014
Yi-Wei Lou Pao-Yuan Wang Shih-Chi Yeh Po-Kai Chuang Shiou-Ting Li Chung-Yi Wu Kay-Hooi Khoo Michael Hsiao Tsui-Ling Hsu Chi-Huey Wong

Glioblastoma multiforme (GBM), the grade IV astrocytoma, is the most common and aggressive brain tumor in adults. Despite advances in medical management, the survival rate of GBM patients remains poor, suggesting that identification of GBM-specific targets for therapeutic development is urgently needed. Analysis of several glycan antigens on GBM cell lines revealed that eight of 11 GBM cell lin...

2014
Jyoti Verma Sumit Lal Cornelis JF Van Noorden

Glioblastoma multiforme (GBM) is the most common and most aggressive malignant primary brain tumor in humans. Current GBM treatment includes surgery, radiation therapy, and chemotherapy, sometimes supplemented with novel therapies. Despite recent advances, survival of GBM patients remains poor. Major challenges in GBM treatment are drug delivery across the blood-brain barrier, restriction of da...

2011
Mark Woerner Jingqin Luo Kristin R. Brown Erin Jackson Sonika M. Dahiya Paul Mischel Jeffrey L. Benovic David Piwnica-Worms Joshua B. Rubin

Department of Pediatrics, Division of Biostatistics, Bright Institute, Department of Pathology and Immunology, Molecular Imaging Center, Mallinckrodt Institute of Radiology, Cell Biology and Physiology, Department of Anatomy and Neurobiology, Washington University School of Medicine, St Louis, MO, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, Department...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید